Fundraising Fox
/Companies
Sign in

Anto Biosciences

YC F25

San Francisco, US · Founded 2025 · 4 employees · 11 known investors

Find your way into Anto Biosciences

Sign up to see every warm intro you have to Anto Biosciences

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Anto Biosciences team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Anto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.

Also known as Anto

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesArtificial IntelligenceGenerative AIGenomicsDrug discoveryUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (F25)

Anto Biosciences was founded in 2025 by Arvid E. Gollwitzer and David de Gruijl.

AEArvid E. Gollwitzer
Arvid E. GollwitzerCEOArvid E. Gollwitzer is a researcher with experience at the Broad Institute, Harvard, and MIT, and has held a lecturer position at ETH Zurich. He is the founder of Anto Biosciences.
DDDavid de Gruijl
David de GruijlCTODavid de Gruijl is a co-founder of Anto Biosciences with prior experience at Janssen Pharmaceuticals and research affiliations with ETH Zurich and the Gastroenterology Department at Brigham and Women's Hospital, Harvard Medical School.

Investors · 11

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · funding news · open dataset · 5k.vc investor directory · Not right? Tell us

007 Venture Partnersreported

How we know: Y Combinator's founder network · Not right? Tell us

C10 LabsreportedCambridge

How we know: Y Combinator's founder network · Not right? Tell us

Demos Strategic Investing Partnersreported

How we know: Y Combinator's founder network · Not right? Tell us

FAST — by GETTYLABreportedSan Francisco · $100K

How we know: Y Combinator's founder network · Not right? Tell us

Massive Tech VenturesreportedSeattle

How we know: Y Combinator's founder network · Not right? Tell us

PageOne Lab, Inc.reported

How we know: Y Combinator's founder network · Not right? Tell us

Ritual CapitalreportedMenlo Park · $100K – $500K

How we know: Y Combinator's founder network · Not right? Tell us

Standard Partners Managementreported

How we know: Y Combinator's founder network · Not right? Tell us

Tekedia CapitalreportedLagos · $1K

How we know: press coverage · Y Combinator's founder network · Not right? Tell us

The YC application· Fall 2025 batch

Anto Biosciences - YC F25 - Launch Video

Arvid E. Gollwitzer

Related companies · 8

Octant BioOctant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.
Talus BioTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.
Arpeggio BioArpeggio Bio develops pharmaceutical drugs that target transcription factors using artificial intelligence and RNA-sequencing technology, with lead programs in development for melanoma treatment and rare disease applications.
Sequence BioSequence Bio discovers genetic causes of disease within Newfoundland and Labrador's founder population to develop breakthrough treatments, diagnostics, and preventions. The company focuses on translational biology and genetics research for patients globally.
Kernal BiologicsKernal Bio is a synthetic biology company developing selective mRNA drugs to treat serious illnesses, with a focus on cancer therapeutics and improving patient outcomes.
Intuitive BiosciencesIntuitive Bio develops Colony Surveillance Assays (CSA), diagnostic kits for screening laboratory animal colonies for exposure to specific pathogens. The kits are designed for research institutions and breeding facilities requiring pathogen-free colony verification.
Helix NanotechnologiesHelix Nanotechnologies develops mRNA-based therapeutics for disease treatment and environmental applications, currently advancing a COVID-19 vaccine candidate for immunocompromised patients and testing interventions targeting climate challenges.
Engage BioEngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.

Companies working in the same space as Anto Biosciences.

Legal entities · 1

corporate structure
Anto Biosciences, Inc.

In the news

Anto Biosciences: A Foundation Model for Microbial Communitiesycombinator.com · Nov 2025Anto Biosciences Funding: $1M | Complete Analysis | Extruct AIextruct.ai

Frequently asked questions

What does Anto Biosciences do?
Anto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.
Who founded Anto Biosciences?
Anto Biosciences was founded by Arvid E. Gollwitzer, David de Gruijl in 2025.
Who are Anto Biosciences's investors?
Anto Biosciences's investors include RRE Ventures, Y Combinator, 007 Venture Partners, C10 Labs, Demos Strategic Investing Partners, FAST — by GETTYLAB, Massive Tech Ventures, PageOne Lab, Inc. and 3 more.
Where is Anto Biosciences headquartered?
Anto Biosciences is headquartered in San Francisco, US.